Skip to main content



Local Cdiff information for Nevada

Nevada

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Nevada.



Local Cdiff information for Nevada

Nevada

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Nevada.

Providers

Dr. GI Consultants

GI Consultants
1520 Virginia Ranch Road
Suite 2B, 2nd floor
Gardnerville, 89410
(775) 783-4818
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 739
Hospital Onset: 739
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.64
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: Yes
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: Yes
Law/Regulation: Not available
STATUTE >

State Contact

Kimisha Griffin, MPH
Health Surveyor II
Nevada State Health Division
Office of Public Health Informatics & Epidemiology
3811 W. Charleston Ste 205
Las Vegas, 89102
(702) 486-3568
(702) 486-0494
EMAIL KIMISHA GRIFFIN, MPH >

CLINICAL TRIALS

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older